Failure of rIL-12 administration to inhibit established IgE responses in vivo is associated with enhanced IL-4 synthesis by non-B/non-T cells

International Immunology

Volumn 12, Issue 7, 2000, Pages 1025-1034

  Rempel, Julia D ^a,b   Wang, MingDong ^a   HayGlass, Kent T ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Department of Neuropharmacology ^*  (United States)

Author keywords

IL 12; IL 4; Immediate hypersensitivity; Non B non T

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; OVALBUMIN; RECOMBINANT INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CELL FUNCTION; CELL STIMULATION; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HELPER CELL; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; IN VIVO STUDY; LYMPHOCYTE; LYMPHOCYTE CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0033895230     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/12.7.1025     Document Type: Article

References (53)

1. Immunotherapy of allergic disease
2. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: More similarities than differences
3. Induction and regulation of the IgE response
4. The IL-12/IL-12-receptor system: Role in normal and pathologic immune responses
5. The taming of IL-12: Suppressing the production of proinflammatory cytokines
6. Regulation of IL-12 receptor expression in early T-helper responses implies two phases of T(h)1 differentiation: Capacitance and development
7. IL-12-deficient mice are defective in IFN-Γ production and type 1 cytokine responses
8. T lymphocyte differentiation in the periphery
9. Cytokines induce the development of functionally heterogeneous T helper cell subsets
10. IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: Enhancement by simultaneous B7-1 expression
11. IL-12 is an effective adjuvant for induction of mucosal immunity
12. Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: In vitro and in vivo production of biologically active IL-12
13. Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors
14. Sterile protection of monkeys against malaria after administration of interleukin-12
15. Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites
16. Administration of interleukin-12 prevents mite Der p 1 allergen-IgE antibody production and airway eosinophil infiltration in an animal model of airway inflammation
17. Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes
18. + T lymphocytes
19. + cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy
20. Effects of IL-12 on helper T cell-dependent immune responses in vivo
21. In vivo IL-12 administration induces profound but transient commitment to T helper cell type 1-associated patterns of cytokine and antibody production
22. Multiple effects on peripheral hematology following administration of recombinant human interleukin 12 to nonhuman primates
23. The toxicology of interleukin-12: A review
24. Chemically modified antigen preferentially elicits induction of T(h)1-like cytokine synthesis patterns in vivo
25. 3H- thymidine incorporation with MTT and MTS based bioassays for human and murine IL-2 and IL-4 analysis: Tetrazolium assays provide markedly enhanced sensitivity
26. Anti-IFN-γ treatment blocks the ability of glutaraldehyde-polymerized allergens to inhibit specific IgE responses
27. + bone marrow and splenic non-B, non-T cells are highly enriched in the capacity to produce IL-4 in response to immobilized IgE, IgG2a or ionomycin
28. IgE receptor-positive non-B/non-T cells dominate the production of interleukin 4 and interleukin 6 in immunized mice
29. Mouse splenic and bone marrow cell populations that express high-affinity Fc epsilon receptors and produce interleukin 4 are highly enriched in basophils
30. Non-T cell-derived IL-4 plays an important role in IgE production induced by antigen resensitization and is resistant to FK506
31. In vitro maturation of human neonatal CD4 T lymphocytes. I. Induction of IL-4-producing cells after long-term culture in the presence of IL-4 plus either IL-2 or IL-12
32. IL-12: Initiation cytokine for cell-mediated immunity
33. Therapeutic strategies for allergic diseases
34. Interfering with chemokine networks-the hope for new therapeutics
35. Chemokines in allergy
36. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells
37. Mucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity
38. Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression
39. Induction of interferon γ production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers
40. Production of natural killer cell stimulatory factor by peripheral blood mononuclear cells
41. Interlukin 12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immuno deficiency mice with listerisosis, and interleukin 10 is a physiologic antagonist
42. Natural killer cell stimulatory factor induces T helper type 1 (T(h)1)-specific immune responses and inhibits the development of IL-4-producing T(h) cells
43. + allergen-specific T(h)2 T cell clones
44. Selective expression of an interleukin-12 receptor component by human T helper 1 cells
45. Regulation of the interleukin (IL)-12R β2 subunit expression in developing T helper 1 (T(h)1) and T(h)2 cells
46. Administration of IL-12 during ongoing immune responses fails to permanently suppress and can even enhance the synthesis of antigen-specific IgE
47. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response
48. IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophil
49. NKT cells are phenotypically and functionally diverse
50. + natural T cells with distinct cytotoxic activities and T(h)1, T(h)2, and T(h)0 cytokine secretion patterns
51. Lipid antigen presentation in the immune system: Lessons learned from CD1d knockout mice
52. IL-18 is a potent coinducer of IL-13 in NK and T cells: A new potential role for IL-18 in modulating the immune response
53. IL-4-producing gamma delta T cells that express a very restricted TCR repertoire are preferentially localized in liver and spleen